Acuta Capital Partners, LLC Agios Pharmaceuticals, Inc. Put Options Transaction History

Acuta Capital Partners, LLC

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q1 2018 May 15, 2018	SELL	$59.83 - $86.53 $2.39 Million - $3.46 Million	-40,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$52.12 - $72.33 $2.08 Million - $2.89 Million	40,000	40,000 $2.29 Million

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuta Capital Partners, LLC with notifications on news.